Trial intelligence / Profile preview

Phase II trial of oral udenafil hydrochloride tablets in men with erectile dysfunction

CTR20182285Phase 2Completed

Sponsor
Tasly Group
Start
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of udenafil in erectile dysfunction (ED), sponsored by Tasly Group. Started Dec 2018; status: completed.

02

Drugs

udenafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on CTR20182285.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20182285.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call